• Je něco špatně v tomto záznamu ?

Retinoic acid attenuates the mild hyperoxic lung injury in newborn mice

Magdalena Zimová-Herknerová, Jaromír Mysliveček, Petr Potměšil

. 2008 ; 57 (1) : 33-40.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07511521

Neonatal exposure to hyperoxia alters lung development in mice. We tested if retinoic acid (RA) treatment is capable to affect lung development after hyperoxic injury and to maintain structural integrity of lung. The gene of vascular endothelial growth factor A (VEGF-A) is one of the RA-responsive genes. Newborn BALB/c mice were exposed to room air, 40% or 80% hyperoxia for 7 days. One half of animals in each group received 500 mg/kg retinoic acid from day 3 to day 7 of the experiment. At the end of experiment we assessed body weight (BW), lung wet weight (LW), the wet-to-dry lung weight ratio (W/D) and the expression of mRNA for VEGF-A and G3PDH genes. On day 7 the hyperoxia-exposed sham-treated mice (group 80) weighed 20% less than the room air-exposed group, whereas the 80% hyperoxic group treated with RA weighed only 13% less than the normoxic group. W/D values in 80 and 80A groups did not differ, although they both differed from the control group and from 40 groups. There was a significant difference between 40 and 40A groups, but the control group was different from 40 group but not from 40A groups. The 80 and 80A groups had mRNA VEGF-A expression lowered to 64% and 41% of the control group. RA treatment of normoxic and mild hyperoxic groups increased mRNA VEGF-A expression by about 50%. We conclude that the retinoic acid treatment of newborn BALB/c mice exposed for 7 days to 80% hyperoxia reduced the growth retardation in the 80 % hyperoxic group, reduced the W/D ratio in the 40% but not in the 80 % hyperoxic group. Higher VEGF-A mRNA expression in the 80% hyperoxic group treated with RA was not significant compared to the 80% hyperoxic group.

Citace poskytuje Crossref.org

Bibliografie atd.

Lit.: 21

000      
04116naa 2200517 a 4500
001      
bmc07511521
003      
CZ-PrNML
005      
20120813105600.0
008      
081031s2008 xr e eng||
009      
AR
024    7_
$a 10.33549/physiolres.930794 $2 doi
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Herknerová, Madgalena $7 xx0093426
245    10
$a Retinoic acid attenuates the mild hyperoxic lung injury in newborn mice / $c Magdalena Zimová-Herknerová, Jaromír Mysliveček, Petr Potměšil
314    __
$a Neonatological Department of General Faculty Hospital, Prague
504    __
$a Lit.: 21
520    9_
$a Neonatal exposure to hyperoxia alters lung development in mice. We tested if retinoic acid (RA) treatment is capable to affect lung development after hyperoxic injury and to maintain structural integrity of lung. The gene of vascular endothelial growth factor A (VEGF-A) is one of the RA-responsive genes. Newborn BALB/c mice were exposed to room air, 40% or 80% hyperoxia for 7 days. One half of animals in each group received 500 mg/kg retinoic acid from day 3 to day 7 of the experiment. At the end of experiment we assessed body weight (BW), lung wet weight (LW), the wet-to-dry lung weight ratio (W/D) and the expression of mRNA for VEGF-A and G3PDH genes. On day 7 the hyperoxia-exposed sham-treated mice (group 80) weighed 20% less than the room air-exposed group, whereas the 80% hyperoxic group treated with RA weighed only 13% less than the normoxic group. W/D values in 80 and 80A groups did not differ, although they both differed from the control group and from 40 groups. There was a significant difference between 40 and 40A groups, but the control group was different from 40 group but not from 40A groups. The 80 and 80A groups had mRNA VEGF-A expression lowered to 64% and 41% of the control group. RA treatment of normoxic and mild hyperoxic groups increased mRNA VEGF-A expression by about 50%. We conclude that the retinoic acid treatment of newborn BALB/c mice exposed for 7 days to 80% hyperoxia reduced the growth retardation in the 80 % hyperoxic group, reduced the W/D ratio in the 40% but not in the 80 % hyperoxic group. Higher VEGF-A mRNA expression in the 80% hyperoxic group treated with RA was not significant compared to the 80% hyperoxic group.
650    _2
$a analýza rozptylu $7 D000704
650    _2
$a zvířata $7 D000818
650    _2
$a novorozená zvířata $7 D000831
650    _2
$a antioxidancia $x farmakologie $7 D000975
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a vývojová regulace genové exprese $x účinky léků $7 D018507
650    _2
$a glyceraldehyd-3-fosfátdehydrogenasy $x metabolismus $x účinky léků $7 D005987
650    _2
$a hyperoxie $x komplikace $x metabolismus $x patologie $7 D018496
650    _2
$a plicní nemoci $x etiologie $x metabolismus $x patologie $x prevence a kontrola $7 D008171
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a plicní alveoly $x metabolismus $x patologie $x růst a vývoj $x účinky léků $7 D011650
650    _2
$a messenger RNA $x analýza $7 D012333
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a genetická transkripce $x účinky záření $7 D014158
650    _2
$a tretinoin $x farmakologie $7 D014212
650    _2
$a vaskulární endoteliální růstový faktor A $x genetika $x metabolismus $x účinky léků $7 D042461
700    1_
$a Mysliveček, Jaromír, $d 1968- $7 nlk19990073583
700    1_
$a Potměšil, Petr $7 xx0102562
773    0_
$w MED00003824 $t Physiological research $g Roč. 57, č. 1 (2008), s. 33-40 $x 0862-8408
856    41
$u http://www.biomed.cas.cz/physiolres/pdf/57/57_33.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 4120 $c 266 $y 1
990    __
$a 20081030145146 $b ABA008
991    __
$a 20120813105649 $b ABA008
999    __
$a ok $b bmc $g 627111 $s 479547
BAS    __
$a 3
BMC    __
$a 2008 $b 57 $c 1 $d 33-40 $i 0862-8408 $m Physiological research $x MED00003824
LZP    __
$a 2008-19/mkme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...